
Viewpoint: A shot in the arm for generics producers
Domino inksThere is nowhere to hide from the Falsified Medicines Directive. It impacts generics producers in the same way as any other drug manufacturer or re-packager selling into Europe. With just under 48 months to go before the deadline, which is likely to be mid-2018, the clock is ticking for all producers to get their house in order.
The subject was hot on the agenda at the European Generics Association (EGA) meeting in Madrid earlier this month. As generics manufacturers often supply products with much lower margins than patented drug producers, their budgets are restricted when it comes to new investment – which is why many of them have been holding out until the last minute to find the ‘best-fit’ solution for their businesses.
Related Posts
Anti-tobacco drive: Health dept wants cooperation from excise
The Punjab health department on Thursday asked the excise and taxation department...
Latvia seizes 5 tons of counterfeit coffee destined for EU market
More than five tons of counterfeit coffee with fake Nestle and Nescafe labels...
250m fake phones sold in Nigeria yearly –NCC
From Walter Ukaegbu, AbujaNEWLY appointed acting Executive Vice Chairman,...
Pattani man arrested with huge haul of smuggled cigarettes
Police and Excise Department officials have arrested a man in Pattani’s Mayo...